When was the last time you sat in a room with 50 senior level pharmaceutical risk management leaders? Or when was the last time you were privy to the outcomes of a “Meeting of the Minds” risk management working group? Now the first time, 50 of the key industry risk management leaders will convene to discuss their concerns, best practices, and next practices in dealing with managing risk under the microscope of post-approval regulation.
The Exclusive Invite-Only Executive Task Force will convene on May 21, 2008. Moderated by Christopher-Paul Milne, Tufts Center for the Study of Drug Development, this comprehensive day will cover your most pressing issues in an informal discussion format.
I. Developing a Risk Management System
II. Lifecycle Management Approach to Drug Safety
III. Balancing the Benefi t/Risk
IV. Global Risk Minimization
THE MAIN EVENT
On May 22nd and 23rd, 2008, the fi ndings of the Executive Task Force will be presented by a panel from the summit working group during the main conference. Not only will you hear from our Executive Task Force Panel, our main conference will provide insights from our expert speaking faculty to improve your risk management strategies for increased drug value and safety.
What’s the next step toward drug safety?
|Hear from Mark McClellan on his vision for implementing an Active Surveillance System.|
Plus! What’s on the Horizon?
Three Featured Sessions that Discuss the Future of Drug Safety and Risk Management in the Pharmaceutical Industry
Can you afford to miss out on this event?
|Register now to be one of the fi rst 50 senior level pharma executives for inclusion in the Executive Task Force!!|
Event Director, Pharmaceutical Division
Institute for International Research